Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: SB Pharmco Puerto Rico Inc.
Current Parent Company: GSK plc
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Recap of Ownership Changes:  subscribe to see this data field
Penalty: $750,000,000
Year: 2010
Date: October 26, 2010
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: SB Pharmco Puerto Rico Inc., a subsidiary of GlaxoSmithKline, PLC, agreed to plead guilty to charges relating to the manufacture and distribution of certain adulterated drugs made at GSK's now-closed Cidra, Puerto Rico, manufacturing facility. The resolution included a criminal fine and forfeiture totaling $150 million and a civil settlement under the False Claims Act and related state claims for $600 million.
Level of Government: federal
Action Type: agency action
Agency: Food and Drug Administration referral to the Justice Department
Civil or Criminal Case: civil and criminal
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.